Spectral flow: fresh blood vs fixed blood comparison on our 25 marker panel

The drug developer’s dilemma: use Peripheral Blood Mononuclear Cells (PBMCs) and lose granulocytes, or use fresh blood, and risk losing 10-20% of samples? To answer this dilemma, we built the TokuKit: teiko.bio/tokukit.